Insider Transactions Reported by 12 Insiders of Bellerophon Therapeutics, Inc.

Location
Warren, NJ

There are no Buy or Sell transactions made by insiders since 28 Dec 2024

Bellerophon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Fernandes Chief Executive Officer, Principal Financial and Accounting Officer $154K 07 Jun 2023
PCM Ai Opportunities Fund 10%+ Owner $112K 07 Jun 2023
Parag Shah VP of Business Operations $77.8K 07 Jun 2023
Martin Dekker VP of Engineering & Manufacturing $77.8K 07 Jun 2023
Nicholas Laccona Financial Officer, (Pfo & Pao) $77.3K 10 Feb 2023
Bobae Kim VP Reg. Affairs & Quality $76.2K 07 Jun 2023
Naseem Amin Director $30.3K 07 Jun 2023
Crispin Teufel Director $22.2K 07 Jun 2023
Scott P. Bruder Director $22.2K 07 Jun 2023
Mary Ann Cloyd Director $22.2K 07 Jun 2023
Theodore T. Wang Director $22.2K 07 Jun 2023
Puissance Capital Management LP 10%+ Owner 13 Oct 2023

Recent Insider Transactions by Companies or Individuals for Bellerophon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.